<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet href="http://www.sgurunews.com/emailmarketer/admin/includes/styles/rssdisplay.php" type="text/xsl"?>
	<rss version='2.0'>
		<channel>
			<title>Email Campaign Archives for list &#039;Stock Guru&#039;</title>
			<description>Email Campaign Archives for list &#039;Stock Guru&#039;</description>
			<generator>N/A</generator>
			<lastBuildDate>Fri, 30 Jul 2010 06:44:08 -0500</lastBuildDate>
			<ttl>20</ttl>
		<item>
			<title>Taking Profits and Looking for the Next Big One: VSYS – TWO TRADING DAYS UP AS MUCH AS 43%</title>
			<description>Taking Profits and Looking for the Next Big One: VSYS – TWO TRADING DAYS UP AS MUCH AS 43%</description>
			<author>jpentony</author>
			<pubdate>Thu, 29 Jul 2010 13:26:02 -0500</pubdate>
			<subject>Taking Profits and Looking for the Next Big One: VSYS – TWO TRADING DAYS UP AS MUCH AS 43%</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
StockGuru                        Spotlight Update:
 StockGuru Spotlight - July 29, 2010  
 DAFX, CDFB, SMME, MINE, DTRO, NRDS, VXGN  
 Dear Members:
 Take a look at SELR.  This has been a double pick recently because we feel like this is a great trading stock.  You have had many opportunities since July 7, our original pick date, when it was trading at $0.25.  We picked it again just two weeks later because of its great movement and the potential to make a great quick trade.  It was at $0.35 on our second pick date of July 21, 2010.  Yesterday it hit a high of $0.41.  Watch this stock.  From our original pick date it is up as much as 64%.    There has been plenty of room in this movement to take some solid money off the table.
 
 SELR Stock Guru Announcement ---  SELR Press Release
 StockGuru ON FIRE PICK
 VSYS - TWO TRADING DAYS UP AS MUCH AS 43%
 
 VSYS Stock Guru Announcement ---  VSYS Press Release
 Last night we brought you our Short Term On Fire Stock Guru Picks.
 Did you cash in on our recent ON FIRE Stock Guru Spotlight Picks.  Check Out the charts below --- PTSC, CMIN, MBCI.
 PTSC - FIVE TRADING DAYS - UP as much as 105%
 CMIN - ONE TRADING DAY - UP AS MUCH AS 33%
 MBCI - ONE TRADING DAY UP AS MUCH AS 55%
 Trading the StockGuru way mean taking PROFITS.  Have You Taken Yours?
 Our Stock  Guru Picks are based on recent news releases -- and we   prove our picks  are real by issuing press releases on the date of the   pick and link you  to those releases!
 Trade the    Stock Guru Way and benefit from these kind of percentage increases.     Don't miss our daily Spotlight or our Evening Round UP.  We focus on    companies you should have on your radar and provide our tips on Trading    the Stock Guru Way -- a proven system.  It is hard to argue with Stock    Guru Success!
 Get on Board - the Stock Guru Trading Way.
 Have you been a Spotlight Fan?  If so you have cashed in on our many previous spotlights.  Check them OUT.
 
 Get on Board - the Stock Guru Trading Way.
 
 PTSC Stock Guru Announcement ---  PTSC Press Release
 
 
 CMIN Stock Guru Announcement ---  CMIN Press Release
 
 MBCI Stock Guru Announcement ---  MBCI Press Release
  
  
 We are NOT compensated in any way for these Spotlight Picks.  If we    decide to include a pick for which we are compensated you will be    clearly informed.
 While you can    never catch the exact high StockGuru shows you the potential when you    learn to trade the StockGuru Way.  We look at the news that moves the    stocks -- good and bad.  StockGuru brings you trading news you can  use   and meaningful trend
 Our StockGuru Spotlight Picks Are Published Before the Open Each Morning
 StockGuru Spotlights are featured on our web site. We have an RSS feed and an exclusive twitter feed for StockGuru Spotlights.
 We also issue    press releases on the StockGuru Spotlights; you can see proof  positive   our notice to you is truly an advanced notice.
 StockGuru is not not jumping on these after they move.
 Here is the link to BOOKMARK for Spotlights:
 http://www.stockguru.com/tag/spotlight
 Don't Miss Our on Spotlight Stocks!
 
 
  
 Don't Miss Our on Spotlight Stocks!
  
 Our StockGuru Spotlight Picks Are   Published Before the Open   Each Morning
 StockGuru Spotlights are featured on our web site.   We have an RSS feed and an exclusive twitter feed for StockGuru Spotlights.
 We also issue press releases on the StockGuru   Spotlights; you can see proof positive our notice to you is truly an advanced   notice.
 StockGuru is not not jumping on these after they   move.
 Here is the link to BOOKMARK for   Spotlights:
 http://www.stockguru.com/tag/spotlight
 

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                            RSS FEED.
  
 
  
  

 
Suggest                        a Client:
 Do                        you know a great company that simply must be featured on                        StockGuru or Shareholder Vision?
 Suggest                        it to us.
 Email: john@stockguru.com   Tel: (469) 252-3031.








 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM                      and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco,                      Texas 75035. (469) 252-3030
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=919</link>
		</item>
				<item>
			<title>Breaking News VCRT: Vicor Technologies&#039; Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting</title>
			<description>Breaking News VCRT: Vicor Technologies&#039; Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting</description>
			<author>jpentony</author>
			<pubdate>Wed, 28 Jul 2010 13:11:02 -0500</pubdate>
			<subject>Breaking News VCRT: Vicor Technologies&#039; Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
Breaking News: Vicor Technologies, Inc.                        (OTCBB: VCRT)
 
 Vicor Technologies, Inc. (OTCBB: VCRT)
 
 
Vicor Technologies' Chief Medical Officer to Present Abstract on Hypovolemia Study Results at the AABB 2010 Annual Meeting
  
 BOCA RATON, FL--(Marketwire - 07/28/10) - David H. Fater, CEO of Vicor Technologies, Inc. (OTC.BB:VCRT - News), today announced that Vicor Chief Medical Officer Dr. Daniel Weiss will present an abstract of the results of a pilot study to test the ability of Vicor's PD2i&reg; nonlinear algorithm to detect acute hypovolemia at the AABB 2010 Annual Meeting. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i&reg; nonlinear algorithm and software. Vicor is currently in the process of commercializing diagnostics that accurately risk stratify specific target populations for future pathological events including cardiac death resulting from arrhythmia or pump failure, and autonomic nervous system dysfunction, and trauma victims in need of lifesaving intervention.
 Dr. Weiss will present Mild Hemorrhage Results in Observable Changes in Heart Rate Variability (S106-040B) on October 12, 2010 at 3:15pm in room 339/340, during the session entitled Donor Recruitment, Retention and Adverse Events: Hemoglobin and Iron. The AABB Annual Meeting &amp; CTTXPO 2010 will be held at the Baltimore Convention Center on October 9-12, 2010.
 "We're honored to have Dr. Weiss's abstract of our hypovolemia study selected for presentation before this prestigious group. We believe the results achieved by the PD2i&reg; in this small pilot study suggest the prospect of incorporating the PD2i&reg; nonlinear algorithm into a noninvasive diagnostic for use in identifying patients who are bleeding internally. We hope that having the opportunity to share these results with those active in the field of transfusion medicine and cellular technologies worldwide will further opportunities to advance study of the PD2i&reg; as a noninvasive diagnostic to detect acute hypovolemia, and further our commercialization efforts for the PD2i&reg;," stated Mr. Fater.
 The study on which the abstract is based was conducted in cooperation with the University of Mississippi Medical Center and Mississippi Blood Services on December 12, 2009 in Smithdale, MS. The goal of the study was to test the ability of Vicor's PD2i&reg; nonlinear algorithm to identify acute hypovolemia in blood donors as a preliminary step toward ascertaining whether it could be a useful noninvasive diagnostic for detecting blood loss from internal bleeding. All 18 participants in the pilot study were tested prior to donation to determine a baseline PD2i&reg; value, and re-tested during and after collection. The average PD2i&reg; value of participants prior to donation was 2.60; the average PD2i&reg; value following donation was 1.80. With a P value of 0.001, the study results are highly statistically significant; this indicates a better than 99% probability that the results were not achieved randomly.
 The AABB is an international, not-for-profit association representing individuals and institutions involved in the field of transfusion medicine and cellular therapies. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership consists of nearly 2,000 institutions and 8,000 individuals, including physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. Members are located in more than 80 countries.
 About Vicor Technologies, Inc.  Vicor Technologies is focused on commercializing innovative non-invasive diagnostics employing its patented, proprietary point correlation dimension algorithm (PD2i&reg;). The PD2i&reg; nonlinear algorithm is a deterministic, nonlinear measure of electrophysiological potentials that predicts future pathological events with a high degree of accuracy in target populations.
 The PD2i Analyzer&trade;, which has FDA 510(k) marketing clearance, measures heart rate variability. Physicians performing diagnostic tests with the PD2i Analyzer&trade; are able to receive reimbursement under existing CPT codes. The PD2i VS&trade; (Vital Sign), in clinical trials under a collaborative effort with the U.S. Army Institute for Surgical Research (http://www.usaisr.amedd.army.mil/), risk stratifies combat and civilian trauma victims. The PD2i CA&trade; (Cardiac Analyzer), in various clinical trials, identifies patients at elevated risk of cardiac death resulting from arrhythmia or pump failure.
 Vicor anticipates developing additional applications utilizing the PD2i&reg; nonlinear algorithm to enable early detection and risk stratification for a variety of other disorders and diseases. Additional information is available at www.vicortech.com.
 Disclaimer  The appearance of name-brand institutions or products in this media release does not constitute endorsement by the U.S. Army Medical Research and Materiel Command, the Department of the Army, Department of Defense, the U.S. Government, or the AABB of the information, products or services contained therein.
 Caution Regarding Forward-Looking Statements  Forward-looking statements in this press release are based on current plans and expectations that are subject to uncertainties and risks, which could cause our future results to differ materially. The following factors, among others, could cause our actual results to differ: our ability to generate revenues from the sale of the PD2i Analyzer&trade;; our ability to obtain FDA approval of our 510(k) submission to secure a claim for the PD2i CA&trade;(Cardiac Analyzer) for risk stratifying congestive heart failure patients at elevated risk of cardiac mortality and our ability to obtain marketing clearance from the FDA for the PD2i VS&trade; (Vital Sign) for military and civilian applications; our ability to continue to receive financing sufficient to continue operations and complete critical clinical trials; our ability to continue as a going concern; our ability to successfully develop products based on our technologies; our ability to obtain and maintain adequate levels of third-party reimbursement for our products; the impact of competitive products and pricing; our ability to receive regulatory approval for our products; the ability of third-party contract research organizations to perform preclinical testing and clinical trials for our technologies; the ability of third-party manufacturers to manufacture our products; our ability to retain the services of our key personnel; our ability to market and sell our products successfully; our ability to protect our intellectual property; product liability; changes in federal income tax laws and regulations; general market conditions in the medical device and pharmaceutical industries; and other matters that are described in Vicor's Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and subsequent filings with the Securities and Exchange Commission. Forward-looking statements in this press release speak only as of the date of the press release, and we assume no obligation to update forward-looking statements or the reasons why actual results could differ.
  


  
 
 
 Vicor Technologies, Inc. (OTCBB: VCRT)
 Introduction
 Vicor Technologies, Inc. (OTCBB: VCRT) is in the crucial  transformative stage for a biotechnology company on the verge of  becoming a viable commercial enterprise.
 This biotechnology company is focused on the commercialization of  innovative, non-invasive medical devices and diagnostics using its  patented, proprietary PD2i&trade; nonlinear algorithm and software which is:

 Highly accurate
 Provides user friendly data acquisition
 Effective for trauma triage easily deployed in a portable monitor
 Provides a simple noninvasive test for identifying patients at risk of sudden cardiac death
 Provides a simple noninvasive test for identifying patients with Diabetic Autonomic Neuropathy

 The  PD2i Algorithm and software risk stratifies target populations to  predict future pathological events. As a predictor of sudden cardiac  death it has been shown to be highly accurate, with a sensitivity  approaching 100% and a specificity of ~86%.
 The advantage of the PD2i&trade; nonlinear algorithm is that it typically  uses recordings made at rest and does not require stress-testing or any  active participation from the patient. The test is relatively  impervious to data non-stationarities and artifacts, setting it apart  from other measures with unparalleled sensitivity.
 A large physician shareholder base represents the early adoptees of this Company.
 Vicor&rsquo;s PD2i&trade; Nonlinear Algorithm is:

 A new vital sign with the ability to actually save lives in both combat and civilian setting
 The PD2i Analyzer&trade; can capture and display Heart Rate Variability  (see defined below) in patients at rest and during paced respiration  and controlled exercise.
 Able to identify trauma victims in need of an immediate lifesaving intervention
 Able to be used along with other clinical data to identify patients at risk of sudden cardiac death
 Able to be used along with other clinical data to identify patients who have autonomic dysfunction
 Able to improve trauma triage in real world situations and on the  battlefield where time is of the essence and the collection of &lsquo;clean&rsquo;  data is never guaranteed
 Able to provide consistently accurate results which requires just one to two minutes of EKG data in a trauma setting
 Not derailed in delivering actionable results by noisy raw EKG data
 Functional in trauma environments and battlefield situations

  
 READ THE FULL STOCKGURU PROFILE HERE:
 http://www.stockguru.com/about/vicor/

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                            RSS FEED.
  
 
  
  

 
Suggest                        a Client:
 Do                        you know a great company that simply must be featured on                        StockGuru or Shareholder Vision?
 Suggest                        it to us.
 Email: john@stockguru.com   Tel: (469) 252-3031.







 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM. 10604 Robincreek Lane; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated fifty thousand restricted common shares and seventy-two hundred dollars by the company for profile coverage for the period ending March 31, 2010. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We will not be buying or selling shares of Vicor during the promotional period.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=918</link>
		</item>
				<item>
			<title>Breaking News OCTI: Quantum Energy, a Division of Octus, Awarded Contract for Hampton Inn &amp; Suites Energy Efficiency Retrofit Project</title>
			<description>Breaking News OCTI: Quantum Energy, a Division of Octus, Awarded Contract for Hampton Inn &amp; Suites Energy Efficiency Retrofit Project</description>
			<author>jpentony</author>
			<pubdate>Tue, 27 Jul 2010 13:46:02 -0500</pubdate>
			<subject>Breaking News OCTI: Quantum Energy, a Division of Octus, Awarded Contract for Hampton Inn &amp; Suites Energy Efficiency Retrofit Project</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
Breaking News: Octus Energy (OTCBB: OCTI)

  
 Octus Energy (OTCBB: OCTI)
 VIEW                        THE PROFILE   
Quantum Energy, a Division of Octus, Awarded Contract for Hampton Inn &amp; Suites Energy Efficiency Retrofit Project
 DAVIS, CA, Jul 27, 2010 (MARKETWIRE via COMTEX) -- Quantum Energy Solutions, the energy project development division of Octus, Inc. (OTCBB: OCTI), today announced it has been awarded a contract for an energy-efficient lighting retrofit project for the Hampton Inn &amp; Suites property in Lodi, California.
   The energy efficiency project involves retrofit of the hospitality property's interior and exterior lighting fixtures, including replacement of 100-watt metal halide parking lot fixtures with 40-watt induction fixtures. The project will be subsidized in part through Lodi Electric Utility's $586,200 in American Recovery and Reinvestment Act of 2009 (ARRA) funds for energy efficiency programs granted to the municipal-owned utility.
 "This project is a true win-win-win," said Quantum President Jim Collins. "Octus profits and stimulates the regional economy, the Hampton Inn &amp; Suites significantly reduces its energy costs, and Lodi Electric benefits by helping one of its customers slash their electricity use. The Stimulus is working, and Hampton Inn &amp; Suites and Lodi Electric should be commended for their smart decision to deploy innovative energy efficiency solutions."
 "The energy savings associated with this project are significant," said Rob Lechner, manager of customer service and economic development coordinator with Lodi Electric Utility. "We salute Hampton Inn &amp; Suites, along with Geweke Properties, for pursuing this excellent energy conservation project. They will reap the benefits of the project for years and years to come."
 About Octus Octus, Inc. (OTCBB: OCTI) is a smart energy efficiency company headquartered in Davis, California that significantly reduces the energy costs of commercial and institutional buildings through energy-efficient lighting, HVAC and energy management systems. Octus monetizes the energy savings it creates through three business units: Smart Energy Technologies, Energy Project Development and the Octus Smart Energy Platform. Octus's energy project development division, Quantum Energy Solutions, has completed more than 1,500 smart energy projects for 300-plus clients including ARCO, Bank of America, Blockbuster, Chevron, Delta Airlines, Frito Lay, Hewlett-Packard, Home Depot, Ikea, Nabisco, Pepsi, Petco, Safeway, Sears, Siemens, and University of California.
  
  
  

  
 Octus Energy (OTCBB: OCTI)
 VIEW                        THE PROFILE
  
  
 
  
  
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                            RSS FEED.
  
 
  
  

 
Suggest                        a Client:
 Do                        you know a great company that simply must be featured on                        StockGuru or Shareholder Vision?
 Suggest                        it to us.
 Email: john@stockguru.com   Tel: (469) 252-3031.







 
 


 
 
 To stop receiving these emails please unsubscribe.   Disclosure: Pentony Enterprises LLC is STOCKGURU.COM. 10604 Robincreek Lane; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was be compensated two hundred fifty ten thousand seven hundred twenty-four free trading shares from a non-controlling third party. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=917</link>
		</item>
				<item>
			<title>Breaking News SKVI: Skinvisible&#039;s Invisicare Patent Portfolio Strengthens - Hong Kong Patent Granted for Polymer Technology</title>
			<description>Breaking News SKVI: Skinvisible&#039;s Invisicare Patent Portfolio Strengthens - Hong Kong Patent Granted for Polymer Technology</description>
			<author>jpentony</author>
			<pubdate>Tue, 27 Jul 2010 12:51:02 -0500</pubdate>
			<subject>Breaking News SKVI: Skinvisible&#039;s Invisicare Patent Portfolio Strengthens - Hong Kong Patent Granted for Polymer Technology</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
Breaking News: Skinvisible, Inc. (OTCBB: SKVI)
 
Skinvisible, Inc. (OTCBB:SKVI)    StockGuru SKVI Profile
 
Skinvisible's Invisicare Patent Portfolio Strengthens
Hong Kong Patent Granted for Polymer Technology
  
 LAS VEGAS, Jul 27, 2010 (GlobeNewswire via COMTEX) -- Skinvisible, Inc. (OTCBB:SKVI) announced today the Hong Kong Patent Office has issued the Company a patent (No. HK1066971) covering its unique polymer delivery system, Invisicare(R). This comprehensive patent is the fourth granted in Asia and the seventh worldwide. The Invisicare patent adds protection in Hong Kong in the areas of "Topical Composition," "Topical Composition Precursor," and "Methods for Manufacturing and Using."
 "Patent protection represents a key investment for Skinvisible as it provides our products with long-term market exclusivity," said Mr. Terry Howlett, President and CEO of Skinvisible. "Patents strengthen our ability to license our unique product formulations worldwide, as evidenced by our recent agreements in Europe, China and the United States. We are aggressively pursuing additional licensing opportunities for formulations developed with the Invisicare technology."
 The patented Invisicare technology can be applied to a variety of topical products for medical conditions and uses, especially where a controlled release of the active ingredient and substantivity are the desired benefit. Its uniqueness stems from an ability to deliver a wide range of active ingredients, holding them on the skin while providing a controlled release. The cream and gel formulations made with Invisicare have a smooth feel which form an undetectable film that delivers the active ingredient while supporting the skin's natural barrier function. This technology provides life cycle management for topical products that require new patent protection, revitalization and a new story.
 Skinvisible holds patent protection for Invisicare in the United States, Australia, India, China, South Korea, Japan and now Hong Kong. The Company has numerous US and international product patents pending covering both the technology and finished product formulations.
 About Skinvisible Pharmaceuticals, Inc.
 Skinvisible is a research-and-development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time resisting both wash off and perspiration along with controlling the release of actives and reducing irritation. Skinvisible receives a combination of research and development fees, license fees, and royalties for the life of the patent. Skinvisible's value also lies in its ability to continually generate new IP on topical products formulated with Invisicare. www.skinvisible.com &amp; www.invisicare.com
 The Skinvisible, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7744
 Forward-Looking Statements: This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending March 30, 2010).

  
 
 VIEW THE SKINVISIBLE PROFILE
  
  
 .
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                      RSS FEED.






 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 &ndash; (469) 252-3030. Disclosure: Pentony Enterprises LLC entered into an investor relations consulting and market awareness contract on July 12, 2010.  The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. Pentony Enterprises LLC was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program.  This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=916</link>
		</item>
				<item>
			<title>Skinvisible, Inc. (OTCBB: SKVI) RHEI Agreement Penetrates New Markets for SKVI</title>
			<description>Skinvisible, Inc. (OTCBB: SKVI) RHEI Agreement Penetrates New Markets for SKVI</description>
			<author>jpentony</author>
			<pubdate>Mon, 26 Jul 2010 14:56:03 -0500</pubdate>
			<subject>Skinvisible, Inc. (OTCBB: SKVI) RHEI Agreement Penetrates New Markets for SKVI</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
Trade Alert: Skinvisible, Inc. (OTCBB: SKVI)
 
Skinvisible, Inc. (OTCBB:SKVI)    StockGuru SKVI Profile
 
  
 Dear Members:
 Skinvisible, Inc. (OTCBB: SKVI) makes money by licensing its agreement.  The RHEI Pharmaceuticals HK Ltd. is a Hong  Kong-based pharmaceutical company and a subsidiary of Luxembourg-based  Leeward Ventures SICAR SCA.  An exclusive licensing  agreement is  for the commercial/institutional rights for DermSafe(R) Hand  Sanitizer for Europe and China for three  skincare products.
 These two new agreements with RHEI represent $1.5 million in licensing  fees.  In addition on-going royalties will be received on product sales for Skinvisible.
 RHEI  will leverage its affiliate BeoCare Group, a leading medical    consumables manufacturer with facilities in the United States, Europe    and China, to provide access to the institutional / healthcare markets    through its established network of multi-national clients.  Additionally,   RHEI will also sell to its affiliate, Senior Assist NV,  one of the   largest assisted living providers in Belgium, with a chain  of   thirty-three seniors' homes.
 RHEI  is  they are in a prime position to capture significant market  share  and  revenue from these products.  The annual institutional  spending on  incontinence products  in the United States alone reaches  $32+  million. RHEI is in an ideal  position to penetrate this market  with  their regulatory and  commercialization experience and established   client list.
 
 RHEI Pharmaceuticals Ltd. License Agreement 
 RHEI Pharmaceuticals Ltd. (RHEI) is a global pharmaceutical business    development firm, with special focus on bringing core medicines from   the  U.S., Europe and Japan into the fast-growing South-East Asian    marketplace.  This is a Hong Kong-based pharmaceutical company and a   subsidiary of the  Luxembourg-based Leeward Ventures SICAR SCA.  They  are experts in business development, regulatory   approval and clinical  development and have a management team that   combines a Western  approach to pharmaceuticals with a long experience in   Europe, North  America and South-East Asia. They use their development   capabilities  and network of preferred commercial partners to help other    pharmaceutical companies introduce their products into specific niche    markets, such as the European institutional health care market and the    Chinese hospital market. RHEI is headquartered in Hong Kong and has    operations in Belgium, the U.S. and China.
 Skinvisible completed an exclusive license agreement granting RHEI,  the  exclusive rights to three Skinvisible formulations developed using  its  patented Invisicare polymer delivery system in mid July 2010.
 The agreement specifies exclusivity for the products for the  institutional / healthcare market for:

 An adult incontinence  cream
 Skin barrier cream
 Super moisturizer

 Upfront license fees for the territories of Europe and China and   milestone payments based on approvals and launch dates for the United   States are included. In addition, Skinvisible will receive royalties on  sales of the  products. RHEI will be responsible for regulatory filings,  manufacturing  and commercialization of the products.
 John Pentony
 Publisher, StockGuru.com
  
 .

  
 
 VIEW THE SKINVISIBLE PROFILE
  
  
 .
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                      RSS FEED.






 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 &ndash; (469) 252-3030. Disclosure: Pentony Enterprises LLC entered into an investor relations consulting and market awareness contract on July 12, 2010.  The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. Pentony Enterprises LLC was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program.  This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=915</link>
		</item>
				<item>
			<title>StockGuru Issues a Trade Alert for Skinvisible, Inc. (OTCBB: SKVI) </title>
			<description>StockGuru Issues a Trade Alert for Skinvisible, Inc. (OTCBB: SKVI) </description>
			<author>jpentony</author>
			<pubdate>Thu, 22 Jul 2010 12:16:02 -0500</pubdate>
			<subject>StockGuru Issues a Trade Alert for Skinvisible, Inc. (OTCBB: SKVI) </subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
Trade Alert: Skinvisible, Inc. (OTCBB: SKVI)
 
Skinvisible, Inc. (OTCBB:SKVI)    StockGuru SKVI Profile
 
  
 Skinvisible, Inc. (OTCBB: SKVI) See StockGuru SKVI Profile
  
 Dear Members:
 Two days ago SKVI put out a very significant press release. Note that in the release the company is reporting it will be receiving
  
 QUOTING FROM THE RELEASE:
 "These two new agreements with RHEI represent $1.5 million in licensing fees and on-going royalties on product sales for Skinvisible," stated Terry Howlett, President and CEO of Skinvisible. "This agreement provides another opportunity for RHEI to leverage its international affiliates with established client lists in Europe and China. It is an important step in accelerating the worldwide commercialization of Invisicare products, and represents the third DermSafe licensing agreement, with previous agreements covering Canada and South East Asia."
 So in addition to the $1.5 million in licensing fees, the company will have a very significant on-going stream of royalites on product sales.
 At current price levels with the oustanding share count where it is, that is providing a very signficant revenue per share just for this one deal. There is much more to SKVI than this one deal.
 On this basis, it is clear that the shares are undervalued.
 We are issuing a Trade Alert based on this new information.
 READ THE FULL PRESS RELEASE HERE
 Let's all keep watching this one!
 John Pentony
 Publisher, StockGuru.com
  
 .

  
 
 VIEW THE SKINVISIBLE PROFILE
  
  
 .
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                      RSS FEED.






 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 &ndash; (469) 252-3030. Disclosure: Pentony Enterprises LLC entered into an investor relations consulting and market awareness contract on July 12, 2010.  The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. Pentony Enterprises LLC was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program.  This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=914</link>
		</item>
				<item>
			<title>StockGuru Blog INTK: Industrial Nanotech, Inc.&#039;s Patented Nansulate® Thermal Insulation and Mold Prevention Coating Reduces Alaskan Warehouse Heating Costs by 22%</title>
			<description>StockGuru Blog INTK: Industrial Nanotech, Inc.&#039;s Patented Nansulate® Thermal Insulation and Mold Prevention Coating Reduces Alaskan Warehouse Heating Costs by 22%</description>
			<author>jpentony</author>
			<pubdate>Thu, 22 Jul 2010 12:01:03 -0500</pubdate>
			<subject>StockGuru Blog INTK: Industrial Nanotech, Inc.&#039;s Patented Nansulate® Thermal Insulation and Mold Prevention Coating Reduces Alaskan Warehouse Heating Costs by 22%</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
StockGuru                        Blog: Industrial Nanotech, Inc. (Symbol: INTK)
 
 STOCKGURU                        PROFILE- CORPORATE                        WEB SITE
Industrial Nanotech, Inc.'s Patented Nansulate&reg; Thermal Insulation and Mold Prevention Coating Reduces Alaskan Warehouse Heating Costs by 22%
  
 NAPLES, Fla.--(BUSINESS WIRE)--Industrial Nanotech, Inc. (Pink Sheets:INTK - News), an emerging global leader in nanotechnology based energy saving solutions, reported today that the Company's Nansulate&reg; thermal insulation and mold resistant coatings provide effective insulation and protection in all climates, including the harsh climate of Fairbanks, Alaska. Nansulate&reg; was used in the spring of 2009 to insulate a 1250 S.F. commercial warehouse that houses a military and civilian auto sales business. The owner recently shared his year over year heating bills and reported a reduction in his energy costs by 22%. The warehouse was insulated with Nansulate&reg; HomeProtect Clear Coat at a thickness of 3 coats (approximately 7 mils) by coating the ceiling and walls.
 "As you can imagine, heating is a large expense in a climate like Alaska,&rdquo; explained Francesca Crolley, V.P. Business Development for Industrial Nanotech, Inc. &ldquo;Nansulate&reg; is truly an innovation insulation technology and it works extremely well both in hot climates and cold. It has successfully performed in the harsh climates of the Middle East, on offshore oil platforms, and in the frozen tundra of Alaska. One of its other significant benefits is the ability to resist moisture infiltration, which degrades many conventional types of insulation. The excellent UV resistance, mold resistance and corrosion resistance performance qualities provide added value to our customers, so they are not only getting insulation and significant energy savings, but also multiple other protective benefits. Mr. Sherman, who provided us with his actual heating bills from Fairbanks Natural Gas for the period of May 2008 through April 2010, was thrilled with the energy savings that he experienced at his Fairbanks warehouse. He was able to see a significant savings in his energy bill, which directly impacted his business costs. We are thrilled to have customer after customer reduce their heating costs, cooling costs and manufacturing costs by insulating their buildings and equipment with our coatings. The products represent an advancement in energy saving technology that can significantly impact the energy use and related carbon emissions of everyone on the planet.&rdquo;
 Further information on Nansulate&reg; use on this Alaskan Warehouse, you can download a case study at www.nansulatetestimonials.com. Recent news articles can be found at: http://www.nansulate.com/nansulate_news.htm.
 About Nansulate&reg;
 Nansulate&reg; is the Company's patented product line of award winning, specialty coatings containing a nanotechnology based material and which are well-documented to provide the combined performance qualities of thermal insulation, corrosion prevention, resistance to mold growth, fire resistance, chemical resistance and lead encapsulation in an environmentally safe, water-based, coating formulation. The Nansulate&reg; Product Line includes industrial, residential, agricultural and solar thermal insulation coatings. Additional information about the Company and its products can be found at their websites, (www.industrial-nanotech.com) and (www.nansulate.com). Blog: www.nansulate.com/nanoblog, Twitter: www.twitter.com/NanoPioneer, Search &lsquo;Nansulate&rsquo; on Facebook.
 About Industrial Nanotech Inc.
 Industrial Nanotech Inc. is a global nanoscience solutions and research leader and member of the U.S. Greenbuilding Council, the American Solar Energy Society, and an official ALLY organization with the U.S. Dept. of Energy "Save Energy Now" program. The Company develops and commercializes new and innovative applications for sustainable nanotechnology which are sold worldwide.
 Safe Harbor Statement
 Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic and business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
  
  
 OTC:                        INTK
 Visit                        StockGuru for the Full Profile for INTK
  
  
  
  
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                            RSS FEED.
  
 
  
  

 
Suggest                        a Client:
 Do                        you know a great company that simply must be featured on                        StockGuru or Shareholder Vision?
 Suggest                        it to us.
 Email: john@stockguru.com   Tel: (469) 252-3031.







 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated nine thousand dollars and one million one hundred thousand 144 restricted common shares by the company for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.  Pentony Enterprises still holds all shares.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=913</link>
		</item>
				<item>
			<title>CORRECTION: SKVI - Skinvisible, Inc. (OTCBB: SKVI) $1.5M Licensing Fees Paid in Milestones</title>
			<description>CORRECTION: SKVI - Skinvisible, Inc. (OTCBB: SKVI) $1.5M Licensing Fees Paid in Milestones</description>
			<author>jpentony</author>
			<pubdate>Wed, 21 Jul 2010 13:11:03 -0500</pubdate>
			<subject>CORRECTION: SKVI - Skinvisible, Inc. (OTCBB: SKVI) $1.5M Licensing Fees Paid in Milestones</subject>
			<content><![CDATA[ 


 
 
 


 
 


 
 
 
 

 
 
 


 





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
StockGuru Blog: Skinvisible, Inc. (OTCBB: SKVI)
 
Skinvisible, Inc. (OTCBB:SKVI)    StockGuru SKVI Profile
 
  
 Skinvisible, Inc. (OTCBB: SKVI) See StockGuru SKVI Profile
  
 THIS IS A CORRECTION - EARLIER WE STATED THAT THE $1.5 MILLION IN REVENUE WILL BE FROM "ROYALTIES." IT IS FROM LICENSING FEES. ROYALTIES WILL ALSO BE PAID, BUT THAT IS ON TOP OF THE $1.5 MILLION IN LICENSING FEES.
  
 HERE IS HOW OUR PRIOR POST SHOULD HAVE READ:
  
 Dear Members:
 Skinvisible put out a very important press release yesterday.  Most importantly, I take this away:
 Skinvisible Should Be Profitable in 2010
 Yesterday's press release: This is the news the clear indication that SKVI is moving up.  We saw SKVI move UP 25% and that is not surprising.
 $1.5M in Licensing Fees Will Be Paid in Milestones from an incredibly solid firm with business in Europe and CHINA: RHEI.
 There are two new agreements with RHEI which represent $1.5 million in licensing fees and - additional - on-going royalties on product sales for Skinvisible.
 And this means within the next twelve months as RHEI launches the products.
 What this means is that SKVI which has a overhead of less than $100,000/month is now cash flow positive for the next year. 
 When you couple this with royalty and polymer income on products already licensed and SKVI should be profitable in 2010 - the first year since our beginning. In addition we continue to work on other new licensing opportunities.
 RHEI Pharmaceuticals HK Ltd. is a Hong Kong based pharmaceutical company and a subsidiary of Luxembourg-based Leeward Ventures SICAR SCA, have entered into an exclusive licensing agreement for the commercial / institutional rights for DermSafe&reg; Hand Sanitizer for Europe and China. The agreement follows the previously announced July 13th licensing agreement with RHEI for three skincare products including an adult incontinence cream, barrier cream and super moisturizer.
 Profitability is the beginning of very good things for SKVI and its shareholders.  This is a keeper.
 Let's all keep watching this one!
 John Pentony
 Publisher, StockGuru.com
  
READ THE FULL PRESS RELEASE HERE
 Let's all keep watching this one!
 John Pentony
 Publisher, StockGuru.com
  
 .

  
 
 VIEW THE SKINVISIBLE PROFILE
  
  
 .
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                      RSS FEED.






 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 &ndash; (469) 252-3030. Disclosure: Pentony Enterprises LLC entered into an investor relations consulting and market awareness contract on July 12, 2010.  The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. Pentony Enterprises LLC was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program.  This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
 

 
 
 
 












]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=912</link>
		</item>
				<item>
			<title>Breaking News SKVI: Skinvisible, Inc. (OTCBB: SKVI) $1.5M Royalties Paid in Milestones</title>
			<description>Breaking News SKVI: Skinvisible, Inc. (OTCBB: SKVI) $1.5M Royalties Paid in Milestones</description>
			<author>jpentony</author>
			<pubdate>Wed, 21 Jul 2010 12:36:02 -0500</pubdate>
			<subject>Breaking News SKVI: Skinvisible, Inc. (OTCBB: SKVI) $1.5M Royalties Paid in Milestones</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
StockGuru Blog: Skinvisible, Inc. (OTCBB: SKVI)
 
Skinvisible, Inc. (OTCBB:SKVI)    StockGuru SKVI Profile
 
  
 Skinvisible, Inc. (OTCBB: SKVI) See StockGuru SKVI Profile
 Dear Members,
 Skinvisible put out a very important press release yesterday.  Most importantly, I take this away:
 Skinvisible Should Be Profitable in 2010
 Yesterday's press release: This is the news the clear indication that SKVI is moving up.  We saw SKVI move UP 25% and that is not surprising.
 $1.5M in Royalties Will Be Paid in Milestones from an incredibly solid firm with business in Europe and CHINA: RHEI.
 There are two new agreements with RHEI which represent $1.5 million in licensing fees and - additional - on-going royalties on product sales for Skinvisible.
 And this means within the next twelve months as RHEI launches the products.
 What this means is that SKVI which has a overhead of less than $100,000/month is now cash flow positive for the next year. 
 When you couple this with royalty and polymer income on products already licensed and SKVI should be profitable in 2010 - the first year since our beginning. In addition we continue to work on other new licensing opportunities.
 RHEI Pharmaceuticals HK Ltd. is a Hong Kong based pharmaceutical company and a subsidiary of Luxembourg-based Leeward Ventures SICAR SCA, have entered into an exclusive licensing agreement for the commercial / institutional rights for DermSafe&reg; Hand Sanitizer for Europe and China. The agreement follows the previously announced July 13th licensing agreement with RHEI for three skincare products including an adult incontinence cream, barrier cream and super moisturizer.
 Profitability is the beginning of very good things for SKVI and its shareholders.  This is a keeper.
  
READ THE FULL PRESS RELEASE HERE
 Let's all keep watching this one!
 John Pentony
 Publisher, StockGuru.com
  
 .

  
 
 VIEW THE SKINVISIBLE PROFILE
  
  
 .
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                      RSS FEED.






 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 &ndash; (469) 252-3030. Disclosure: Pentony Enterprises LLC entered into an investor relations consulting and market awareness contract on July 12, 2010.  The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. Pentony Enterprises LLC was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program.  This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=911</link>
		</item>
				<item>
			<title>Breaking News SKVI: Skinvisible Signs DermSafe Agreement for Europe and China -- RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to its Product Line</title>
			<description>Breaking News SKVI: Skinvisible Signs DermSafe Agreement for Europe and China -- RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to its Product Line</description>
			<author>jpentony</author>
			<pubdate>Tue, 20 Jul 2010 12:51:03 -0500</pubdate>
			<subject>Breaking News SKVI: Skinvisible Signs DermSafe Agreement for Europe and China -- RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to its Product Line</subject>
			<content><![CDATA[

 
 
 


 
 


 
 
 
 

 
  
 


  





 
 
 






 
 


 
 
 You are subscribed as %%emailaddress%%


 
 
Breaking News: Skinvisible, Inc. (OTCBB: SKVI)
 
Skinvisible, Inc. (OTCBB:SKVI)    StockGuru SKVI Profile
 
 Breaking News SKVI: Skinvisible Signs DermSafe Agreement for Europe and China -- RHEI Pharmaceuticals Adds Alcohol-Free Hand Sanitizer to its Product Line
  
 Skinvisible, Inc. (OTCBB:SKVI), the developers of Invisicare, and RHEI Pharmaceuticals HK Ltd. , a Hong Kong-based pharmaceutical company and a subsidiary of Luxembourg-based Leeward Ventures SICAR SCA, have entered into an exclusive licensing agreement for the commercial/institutional rights for DermSafe(R) Hand Sanitizer for Europe and China. The agreement follows the previously announced July 13th licensing agreement with RHEI for three skincare products, including an adult incontinence cream, barrier cream, and super moisturizer.
 The agreement includes licensing fees payable in milestones based on regulatory approval in Europe and China, anticipated to occur within twelve months or less. RHEI will pay Skinvisible a royalty on product sales and be responsible for seeking regulatory approval, manufacturing, and commercialization. Skinvisible retains rights to DermSafe for the retail/consumer markets within Europe and China. This agreement also provides Skinvisible with all data generated by RHEI to pursue regulatory approvals within the U.S. and internationally.
 "These two new agreements with RHEI represent $1.5 million in licensing fees and on-going royalties on product sales for Skinvisible," stated Terry Howlett, President and CEO of Skinvisible. "This agreement provides another opportunity for RHEI to leverage its international affiliates with established client lists in Europe and China. It is an important step in accelerating the worldwide commercialization of Invisicare products, and represents the third DermSafe licensing agreement, with previous agreements covering Canada and South East Asia."
 "There is a critical need for a safe and effective hand sanitizer made without alcohol for use in hospital and nursing homes," said Peter Vanderbruggen, Managing Director, Leeward Ventures SICAR SCA. "We have been very impressed with the clinical studies conducted on DermSafe on bacteria and viruses, including influenza A viruses, C difficile, and MRSA. We are excited to be working with Skinvisible to introduce this innovative product to our customer base, and to help protect healthcare professionals and their patients."
 DermSafe is a unique, patented hand sanitizer, formulated with 4% chlorhexidine gluconate, an active ingredient used safely, internationally, as a pre-surgical scrub and in periodontal products. DermSafe is made without alcohol, and is proven to kill both bacteria and viruses for up to four hours, even with hand washing.
 About Skinvisible Pharmaceuticals, Inc.
 Skinvisible is a research and development company that licenses its proprietary formulations made with Invisicare, its patented polymer delivery system that offers life-cycle management and unique enhancements for topically delivered products. Invisicare holds active ingredients on the skin for extended periods of time, resisting both wash off and perspiration, along with controlling the release of actives, and reducing irritation. Skinvisible receives a combination of research and development fees, license fees, and royalties for the life of the patent. Skinvisible's value also lies in its ability to continually generate new IP on topical products formulated with Invisicare.

  
 
 VIEW THE SKINVISIBLE PROFILE
  
  
 .
  

 
Live                      Twitter Alerts All Market Day
 Our                        Twitter Feed includes all live posts from StockGuru.com. 
 
Featured                        on StockGuru
 While                        we cover many companies, here are our current featured profiles                        on StockGuru:
  
 Skinvisible, Inc.   (OTCBB: SKVI)
 China Voice Holding Corp   (OTC: CHVC)
 Industrial Nanotech   (OTC: INTK)
 Octus Energy   (OTCBB: OCTI)
 Affinity Mediaworks Corp.   (OTCBB: AFFW)
 Vicor Technologies, Inc.   (OTCBB: VCRT)
 Medizone                        International  (OTCBB: MZEI)
  
 
  
   
StockGuru                        Spotlight Alerts
 Here                        are our latest Spotlight Alerts. Note that we typically                        do NOT email these to members. You must visit the site at THIS                          LINK to keep up to date; or you may subscribe to THIS                      RSS FEED.






 
 


 
 
 To stop receiving these emails please unsubscribe.   Pentony Enterprises LLC is STOCKGURU.COM. 1601 Berwick Drive, McKinney, Texas 75070 &ndash; (469) 252-3030. Disclosure: Pentony Enterprises LLC entered into an investor relations consulting and market awareness contract on July 12, 2010.  The company has agreed to pay us five thousand dollars per month in cash for the period of six months, totaling thirty thousand USD. Pentony Enterprises LLC was previously compensated 500,000 144 restricted common shares by the company for profile coverage for the period ending January 30, 2010. To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program.  This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. To further clarify, we will not be buying or selling shares for the period of July 12, 2010 through January 12, 2011. We hold no shares and will not be receiving further compensation that is share related during this period. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
 

 
 
 
 











]]></content>
			<link>http://www.sgurunews.com/emailmarketer/display.php?List=1&amp;N=910</link>
		</item>
			</channel>
</rss>
